Company
RemeGen Co., Ltd.
RemeGen Co., Ltd. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| RC148 Injection plus Pemetrexed Disodium for Injection and Carboplatin Injection | Phase 3 | Previously Untreated Locally Advanced (IIIB/IIIC) or Metastatic (IV) e Nsq NSCLC Without Actionable Genomic Alterations |
Latest
No recent events.
Follow RemeGen Co., Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.